Central serous chorioretinopathy : from pathogenesis to treatment
Abstract
The aim of this thesis is to increase the understanding of
genetic and clinical aspects of central serous chorioretinopathy, a common
and mysterious chorioretinal disease. Moreover, more insight into the optimal
treatment for central serous chorioretinopathy is provided, since this thesis includes the first randomised controlled trial assessing the outcome of half-dose photodynamic therapy and high-density subthreshold micropulse laser treatment. As central serous chorioretinopathy mainly occurs in middle-aged professionally active patients, and can lead to progressive decline in visual acuity and vision-related quality of life, gaining knowledge on the disease and its treatment is of great importance.
Central serous chorioretinopathyPhotodynamic therapyMicropulse laser treatmentChorioretinal diseaseAge related macular degeneration
